ERYTECH reports financial highlights for Q1 2015 Post author:admERY Post published:May 5, 2015 Post category:Newsroom ERYTECH reports cash balance and revenues for the first quarter of 2015. You Might Also Like ERYTECH Requested a Pre-BLA Meeting with the FDA to Discuss Path to Approval in ALL April 20, 2021 ERYTECH Announces Third DSMB Safety Review and Continuation of Its Phase 2b Study in Acute Myeloid Leukemia January 6, 2016 ERYTECH Announces First Patient Enrolled in a Phase 1 Investigator Sponsored Trial of Eryaspase in First-Line Pancreatic Cancer January 14, 2021
ERYTECH Announces Third DSMB Safety Review and Continuation of Its Phase 2b Study in Acute Myeloid Leukemia January 6, 2016
ERYTECH Announces First Patient Enrolled in a Phase 1 Investigator Sponsored Trial of Eryaspase in First-Line Pancreatic Cancer January 14, 2021
